Modex Therapeutics, An Opko Health Company

This study tests a new drug called MDX2003 in adults with several types of B-cell lymphoma (like DLBCL or follicular lymphoma) that have returned or stopped responding to at least two prior treatments. The main goals are to find the safest dose and check if the drug can shrink tu…

This early-phase trial tests a new drug called MDX2001 in about 285 adults with advanced solid tumors (cancers that have spread). The main goals are to check the drug's safety and find the right dose. Researchers will also see if it shrinks tumors. This is not a cure, but it may …

This study tests a new drug, MDX2004, in about 235 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check the drug's safety and see if it can shrink tumors. Participants must have measurable disease and be in good overall health.

This early-stage study tests a new drug called MDX2301 to see if it can help prevent COVID-19 in healthy adults and those at higher risk for severe illness. About 80 participants will receive either the drug or a placebo by injection or IV. The main goal is to check safety and ho…